Rapact tablets, available in 5 mg and 10 mg strengths, are pharmaceutical products manufactured by Natco Pharma Ltd. These tablets contain Everolimus as the active ingredient. Everolimus is a potent immunosuppressant and anti-cancer agent classified under the mTOR inhibitors category
Category | Anti-neoplastic agents |
Brand | Natco |
Ingredient | Everolimus |
Prescription Required | Yes |
Strength | 5 and 4 mg |
Package | 7 Tablets |
Rapact 5mg and 10mg, which contain Everolimus as the active ingredient, work by inhibiting a protein called mammalian target of rapamycin (mTOR). mTOR is a crucial regulator of cell growth, proliferation, and survival, playing a key role in both the immune system and cancer cell growth. By blocking mTOR, Everolimus suppresses the immune system, which helps prevent organ transplant rejection, and also inhibits the growth and spread of certain types of cancer cells
Rapact 5mg and 10mg, containing Everolimus, offer significant benefits in the treatment of various medical conditions. One of the primary benefits is its ability to prevent organ transplant rejection by suppressing the immune system. By inhibiting the mTOR pathway, Rapact reduces the activation of immune cells that could attack the transplanted organ, thereby helping to prevent rejection and allowing the body to accept the new organ. In addition to its immunosuppressive effects, Rapact also has anti-cancer properties.
The most common side effects of Rapact 5 and 10mg are
• Mouth sores (stomatitis)
• Diarrhea
• Fatigue
• Nausea
• Anemia (low red blood cell count)
• Infections (due to immune suppression)
• Decreased appetite
• Rash
• Fever
• Headache
Other side effects of Rapact 5 and 10mg can include
• Pneumonitis (lung inflammation)
• Severe infections (due to immunosuppression)
• Thrombocytopenia (low platelet count)
• Neutropenia (low white blood cell count)
• Liver toxicity (including jaundice)
• Kidney problems (such as impaired kidney function)
• Elevated cholesterol or triglyceride levels
• Severe allergic reactions (such as difficulty breathing or swelling of the face and throat)
• Gastrointestinal perforation (rare but serious)
• Severe rash or blistering of the skin
Rapact 5mg and 10mg (Everolimus) should not be taken by individuals who have a known hypersensitivity or allergic reaction to Everolimus or any of its components. It is also contraindicated in patients with severe liver impairment, as the drug is metabolized in the liver, and compromised liver function can increase the risk of drug toxicity.
Rapact 5mg and 10mg (Everolimus) should be taken exactly as prescribed by your healthcare provider. Typically, it is taken orally once daily, with or without food. The tablets should be swallowed whole with a glass of water and should not be crushed, chewed, or split, as this may alter the effectiveness of the medication.
There are no reviews yet.